Evidence map›Paper›PMID 33809955›Full record

Observational studyInternational journal of environmental research and public health2021

Trends in Healthcare Access in Japan during the First Wave of the COVID-19 Pandemic, up to June 2020.

Koji Makiyama, Takayuki Kawashima, Shuhei Nomura, Akifumi Eguchi, Daisuke Yoneoka, Yuta Tanoue, Yumi Kawamura, Haruka Sakamoto, Stuart Gilmour, Shoi Shi and 3 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Impact of the COVID-19 and Socioeconomic Status on Access to Care for Otorhinolaryngology Patients.International journal of environmental research and public health · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 1 country.

Koji MakiyamaHOXO-M Inc., 1-22-11 Ginza, Chuo-ku, Tokyo 104-0061, Japan.
Takayuki KawashimaDepartment of Mathematical and Computing Science, Tokyo Institute of Technology, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8550, Japan.
Shuhei NomuraDepartment of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan.ORCID 0000-0002-2963-7297
Akifumi EguchiDepartment of Sustainable Health Science, Center for Preventive Medical Sciences, Chiba University, 1-33 Yayoi-cho, Inage-ku, Chiba 263-8522, Japan.ORCID 0000-0001-5858-8132
Daisuke YoneokaGraduate School of Public Health, St. Luke's International University, 10-1 Akashi-cho, Chuo-ku, Tokyo 104-0044, Japan.ORCID 0000-0002-3525-5092
Yuta TanoueInstitute for Business and Finance, Waseda University, 1-6-1 Nishi-Waseda, Shinjuku-ku, Tokyo 169-8050, Japan.
Yumi KawamuraDepartment of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan.
Haruka SakamotoDepartment of Health Policy and Management, School of Medicine, Keio University, 35 Shinanomachi, Shinjyuku-ku, Tokyo 160-8582, Japan.ORCID 0000-0001-9003-7402
Stuart GilmourGraduate School of Public Health, St. Luke's International University, 10-1 Akashi-cho, Chuo-ku, Tokyo 104-0044, Japan.ORCID 0000-0002-6556-0995
Shoi ShiDepartment of Systems Pharmacology, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8654, Japan.
Kentaro MatsuuraHOXO-M Inc., 1-22-11 Ginza, Chuo-ku, Tokyo 104-0061, Japan.
Shinya UryuCenter for Environmental Biology and Ecosystem Studies, National Institute for Environmental Studies (NIES), 16-2 Onogawa, Tsukuba, Ibaraki 305-8506, Japan.
Masahiro HashizumeDepartment of Global Health Policy, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8654, Japan.ORCID 0000-0003-4720-1750
Keio University · JPSt. Luke's International University · JPChiba University · JPNational Institute for Environmental Studies · JPRIKEN Center for Biosystems Dynamics Research · JPThe University of Tokyo · JPTokyo Institute of Technology · JPTokyo University of Science · JPWaseda University · JP

Funding

Ministry of Health, Labour and Welfare JPMH20HA2007
6 · The paper itself

Abstract

We evaluated the impact of the new coronavirus disease (COVID-19) on healthcare access in Japan in terms of the number of outpatients and hospitalized patients as well as the length of hospital stays, during the first wave of the pandemic, up to June 2020. This observational study evaluated the monthly average number of outpatients per day at hospitals, the average number of hospitalized patients per day, and the average length of hospital stays per patient, from December 2010 to June 2020, using the hospital reports data, which are open aggregated data on the utilization of hospitals from the Ministry of Health, Labour and Welfare. These numbers were compared with those from the same period of previous years, using a quasi-Poisson regression model. We found a nationwide decrease in the number of outpatients in general hospitals and hospitalized patients, particularly in long-term care beds in Japan, as well as the excess length of hospital stays among psychiatric care patients during the first wave of the COVID-19. This limited access to healthcare demonstrated the importance of the long-term health monitoring of vulnerable populations and the need for urgent management support to healthcare facilities in preparation for possible prolonged pandemics in the future.

Indexed as

CoronavirusCOVID-19HumansJapanPandemicsSARS-CoV-2COVID-19healthcare accessJapan

Identifiers

PMID33809955
PMCPMC8004161
OpenAlexW3137806580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.